HIKMA PHARMACEUTIC.LS-,10
HIKMA PHARMACEUTIC.LS-,10/ GB00B0LCW083 /
H5P
5/27/2024 10:58:24 PM
|
Chg.
+0.200
|
Volume |
Bid10:58:24 PM |
Ask10:58:24 PM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
23.000EUR
|
+0.88%
|
- Turnover: - |
23.000Bid Size: - |
23.400Ask Size: - |
5.08 bill.EUR |
- |
- |
Fundamentals
|
FY 2023 |
Growth (1Y) |
Per Share |
|
Earnings per Share: |
0.86 USD |
2.50% |
EPS Diluted: |
- USD |
1.67% |
Revenues per Share: |
13.00 USD |
20.42% |
Book Value per Share: |
9.94 USD |
8.53% |
Cash Flow per Share: |
2.75 USD |
20.94% |
Dividend per Share: |
0.72 USD |
28.57% |
Total |
in mill. |
|
Revenues: |
2,875.00 USD |
14.22% |
Net Income: |
190.00 USD |
1.06% |
Operating Cash Flow: |
608.00 USD |
- |
Cash and Cash Equivalents: |
205.00 USD |
- |
Valuation Ratios
|
Current |
Latest FY* |
P/E Ratio: |
29.03 |
26.51 |
P/S Ratio: |
1.92 |
1.75 |
P/BV ratio: |
2.51 |
2.29 |
P/CF Ratio: |
9.08 |
8.29 |
PEG: |
11.60 |
10.59 |
Earnings Yield: |
3.44% |
3.77% |
Dividend Yield: |
2.88% |
3.16% |
Market Capitalization |
|
Market Capitalization: |
5.08 bill. EUR |
4.57 bill. EUR |
Free Float Market Cap.: |
- EUR |
- EUR |
Market Cap. / Employee: |
- EUR |
- EUR |
Shares Outstanding: |
221.08 mill. |
|
Profitability
Gross Profit Margin: |
48.35% |
EBIT Margin: |
12.77% |
Net Profit Margin: |
6.61% |
Return on Equity: |
8.64% |
Return on Assets: |
4.06% |
Financial Strength
Liquidity I / Cash Ratio: |
15.31% |
Liquidity II / Quick Ratio: |
76.85% |
Liquidity III / Current Ratio: |
156.83% |
Debt / Equity Ratio: |
112.92% |
Dynam. Debt / Equity Ratio: |
408.22% |
Efficiency
Employees: |
- |
Personal Expenses / Employee: |
- USD |
Revenues / Employee: |
- USD |
Net Income / Employee: |
- USD |
Total Assets / Employee: |
- USD |
* Fiscal Year End: |
12/31/2023 |
Accounting Standard: |
IFRS |